John Cox Insider Trading
Get free email notifications about insider trading for John Cox.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Cox. John Cox is a Director in REPLIGEN CORP ($RGEN) and a EVP Pharmaceutical Oper & Tech in BIOGEN INC. ($IDPH) and an Chief Executive Officer in Bioverativ Inc. ($BIVV) and a in Sigilon Therapeutics, Inc. ($SGTX) and a Director in Sigilon Therapeutics, Inc. ($SGTX).
Address: C/O BIOGEN IDEC INC. 133 BOSTON POST ROAD WESTON 02493 MA
Companies in which John Cox is an Insider
BIOGEN INC.
Trading Symbol: IDPHIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John Cox: EVP Pharmaceutical Oper & Tech
Holdings: 39,045 shares
Latest Transaction: Apr 05 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Bioverativ Inc.
Trading Symbol: BIVVIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John Cox: Chief Executive Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 08 2018
$BIVV Market Capitalization: $4637.62B
$BIVV Previous Close: $44.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
REPLIGEN CORP
Trading Symbol: RGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John Cox: Director
Holdings: 923 shares
Current Value: $26,989
Latest Transaction: Mar 26 2020
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sigilon Therapeutics, Inc.
Trading Symbol: SGTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John Cox:
Holdings: 4,444 shares
Latest Transaction: Jun 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John Cox
Sentiment: All, IDPH, BIVV, RGEN, SGTX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | SGTX | Sigilon Therapeuti ... | Cox John | Option Exercise | A | 9.97 | 8,888 | 88,613 | 8,888 | ||
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Cox John | Director | Option Exercise | C | 0.00 | 4,444 | 0 | 0 | |
Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Cox John | Director | Buy | C | 0.00 | 4,444 | 0 | 4,444 | 0 to 4.4 K |
Mar 26 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Sell | S | 96.72 | 1,858 | 179,706 | 923 | 2.8 K to 923 (-66.81 %) |
Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | M | 42.07 | 3,304 | 138,999 | 0 | |
Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | M | 38.76 | 2,434 | 94,342 | 0 | |
Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | M | 26.12 | 3,366 | 87,920 | 0 |